Association Between Serotonin Syndrome and Second‐Generation Antipsychotics via Pharmacological Target‐Adverse Event Analysis

Case reports suggest an association between second‐generation antipsychotics (SGAs) and serotonin syndrome (SS). The US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) was analyzed to generate hypotheses about how SGAs may interact with pharmacological targets associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Racz, Rebecca, Soldatos, Theodoros G., Jackson, David, Burkhart, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944571/
https://www.ncbi.nlm.nih.gov/pubmed/29575568
http://dx.doi.org/10.1111/cts.12543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944571/
https://www.ncbi.nlm.nih.gov/pubmed/29575568
http://dx.doi.org/10.1111/cts.12543

Ejemplares similares